Antibody Production Market to Grow to $58.35 Billion by 2031

Roshani

posted on 3 months ago — updated on 1 second ago

34
views

Antibody Production Market to Grow to $58.35 Billion by 2031

Antibody Production Market by Product [Bioreactors (Single use, Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers, Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit], Process [Downstream, Upstream] – Global Forecast to 2031

Meticulous Research®, a prominent market research organization, has released a comprehensive report titled "Antibody Production Market by Product [Bioreactors (Single Use, Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers, Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit], Process [Downstream, Upstream] – Global Forecast to 2031."

The report forecasts that the antibody production market will experience robust growth, achieving a CAGR of 11.4% from 2024 and reaching $58.35 billion by 2031. Key drivers of this growth include the escalating demand for targeted antibodies, increased R&D investment from pharmaceutical and biotech firms, and the rising incidence of cancer and autoimmune disorders. Additionally, advancements in bioprocessing technologies and the growing application of immunoassays are expected to significantly boost market expansion. However, challenges such as high production costs and stringent regulatory requirements may impede growth.

Emerging markets, particularly in developing countries, present substantial opportunities, driven by the increasing use of antibodies in clinical research and the heightened prevalence of infectious diseases. Nevertheless, the complexity of monoclonal antibodies continues to challenge market participants.

Major players in the market, including Thermo Fisher Scientific Inc. (U.S.), Merck KgaA (Germany), and Danaher Corporation (U.S.), are pivotal in driving market innovation and meeting the increasing global demand.

The market is categorized by product, antibody type, source, process, and end-user. The instruments segment, which comprises bioreactors and chromatography systems, is expected to lead the market in 2024, fueled by the need for mass production and the refinement of antibodies for therapeutic uses. Monoclonal antibodies, in particular, are anticipated to witness the highest growth rate due to their expanding role in treating complex diseases like cancer.

Mice are projected to continue dominating the source segment, owing to their affordability, ease of production, and well-established use in genetic engineering. In terms of processing, downstream methods are likely to capture the largest market share, given their critical role in the purification and recovery of antibodies.

The pharmaceutical and biotechnology sectors are expected to emerge as the fastest-growing end users, driven by increased R&D activities, the expansion of antibody production facilities, and the ongoing development of new antibody-based therapies.

Regionally, North America is poised to lead the antibody production market, followed closely by Europe and Asia-Pacific. This leadership is attributed to advanced technological infrastructure, significant R&D investments, and a high burden of chronic diseases that necessitate innovative biologic therapies.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5769

Key Questions Answered in the Report:

What is the current revenue generated by the products for antibody production across the globe?
At what rate is the demand for products for antibody production projected to grow over the next 5–7 years?
What is the historical market size and growth rate of the global antibody production market?
What are the major factors impacting the growth of this market at the global and regional levels? What are the major opportunities for existing market players and new entrants in the market?
Which segments in terms of product, antibody type, process, source, and end user are creating major traction for the vendors in this market?
What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global antibody production market?
Who are the major players in the global antibody production market? And what are their product offerings in the antibody production market?
What are the recent strategic developments in the global antibody production market, and what are the impacts of these developments on the global market?